Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases - MAESTRO -

NCT05027711 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT05027711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05027711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases - MAESTRO -
Lead sponsor
University Hospital Heidelberg
Phase
Phase 2
Overall status
Recruiting
Start date
August 12, 2021
Completion date
January 31, 2030
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic metastasis